Could you build tolerance to COVID-19?

Leopoldo Nicolas Segal, MD, along with a team of researchers, discovered that a rare type of lung immune cell—called NAMs—helps control inflammation during COVID-19 infection. The study suggests that boosting NAM function through interferon signaling could lead to new treatments that help the body tolerate disease instead of just fighting the virus.